GLP-1 Agonist Semaglutide Brand names: Ozempic (diabetes) Wegovy (weight loss) 1517% Average body weight reduction (STEP trials) Activates GLP-1 receptors in gut and brain Suppresses appetite, slows gastric emptying Regulates blood sugar and insulin response Weekly subcutaneous injection or daily oral (Rybelsus) Cardiovascular outcome data: SELECT trial (2023) Dual GLP-1 + GIP Agonist Tirzepatide Brand names: Mounjaro (diabetes) Zepbound (weight loss) 2022% Average body weight reduction (SURMOUNT trials) Activates both GLP-1 AND GIP receptors Stronger effect on insulin sensitivity than semaglutide alone Greater fat loss, especially visceral fat Weekly subcutaneous injection only Head-to-head vs semaglutide: SURPASS-6 favors tirzepatide The core difference is the receptor target
Patients who have tried structured programs without success If diet and exercise plans havent produced the results you were hoping for, GLP-1 therapy may help address the underlying biological factors involved
While the country still accounts for a third of the worlds undernutrition according to the World Health Organization (WHO), rising incomes and urban lifestyles have pushed obesity rates sharply upward
Other research demonstrates that multi-hormone weight loss therapies targeting GLP-1, GIP, and glucagon are better at preserving muscle than medications targeting only one hormone
How much medicine your body uses varies considerably between people taking the pill form
Suitable For: Adults only or as professionally prescribed Boxed Contents: 90 Capsules Size: 90 Capsules KEY FEATURES Supports energy levels and energy production